Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Eczema
Sort By
Newest First
1 / 1
1 / 1
Pfizer Announces Positive Top-Line Results from Phase 3 Study in Patients with Moderate to Severe Atopic Dermatitis
Pfizer
PR-M05-19-NI-055
May 20, 2019
Drug Development
Novartis Will Spend Up to More Than $1 Billion on an Eczema Candidate
Emilie Branch
Pharma's Almanac
PAO-M07-18-NI-017
Jul 24, 2018
